A customer-first experience
We’re giving the aesthetics process a modern-day makeover, thanks to an open communication style and updated technology.
Thanks to science, there’s help for moderate to severe glabellar lines. What’s a glabellar line? Those pesky little wrinkles between your eyebrows that won’t go away—aka frown lines.1 Meet Jeuveau™—a new FDA-approved injectable treatment that temporarily improves the look of frown lines in adults.
Meet our Injectionists.
What exactly is Jeuveau™?
You know those pesky little wrinkles between your eyebrows that won’t go away? Well, they’re called glabellar lines, or “frown lines.”1Jeuveau™ is an injectable treatment that works to temporarily improve the appearance of moderate to severe frown lines in adults.
How does Jeuveau™ work?
Jeuveau™ prevents your nerves from telling your facial muscles to flex.1 The result? In clinical trials, Jeuveau™ was shown to temporarily improve the appearance of moderate to severe frown lines.1 In 2 long-term safety studies, patients received an average of 3 treatments over the course of 1 year.
What are the results with Jeuveau™?
In our 2 major clinical trials, when we checked at the 30-day mark, 67.5% of patients in 1 study and 70.4% of subjects in a second study were responders defined as a 2-point composite improvement agreed upon by physician and patient.
What are the side effects?
The most commonly reported side effects in clinical trials include headache, eyelid drooping, upper respiratory tract infection and increased white blood cell count.1 No serious drug-related adverse events were observed in the studies.
What’s it like before and after treatment?
If it’s your first time getting a treatment, you may be a little nervous. And that’s okay! Localized pain, infection, inflammation, tenderness, swelling, erythema, and/or bleeding/bruising may be associated with the injection.1
For specific instructions on what to do before and after your injection, please follow the instructions as given to you by your doctor or healthcare provider.